Shopping Cart 0
Cart Subtotal
AED 0

PDL Biopharma, Inc. - Strategy, SWOT and Corporate Finance Report

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 642

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 1285

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1927

Details

PDL Biopharma, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

PDL Biopharma, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

PDL Biopharma, Inc., (PDL or 'the company'), formerly known as Protein Design Labs, Inc., is engaged in the research and development of humanized antibodies for cancer, immunologic diseases and other medical conditions. The company operates in the US, where it is headquartered in Incline Village, Nevada.

Scope

- Detailed information on PDL Biopharma, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting PDL Biopharma, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of PDL Biopharma, Inc. including a breakdown and examination of key business segments

- Intelligence on PDL Biopharma, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about PDL Biopharma, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PDL Biopharma, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess PDL Biopharma, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on PDL Biopharma, Inc.'s business structure, strategy and prospects.

READ MORE

Table Of Content

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

PDL Biopharma, Inc.: Company Overview 9

PDL Biopharma, Inc.: Overview and Key Facts 9

PDL Biopharma, Inc.: Overview 9

PDL Biopharma, Inc.: Key Facts 9

PDL Biopharma, Inc.: Key Employees 11

PDL Biopharma, Inc.: Key Employee Biographies 12

PDL Biopharma, Inc.: Major Products and Services 16

PDL Biopharma, Inc.: Company History 17

PDL Biopharma, Inc.: Management Statement 20

PDL Biopharma, Inc.: Locations and Subsidiaries 21

PDL Biopharma, Inc.: Key Competitors 22

PDL Biopharma, Inc.: Company Analysis 23

PDL Biopharma, Inc.: Business Description 23

PDL Biopharma, Inc.: SWOT Analysis 24

PDL Biopharma, Inc.: SWOT Overview 24

PDL Biopharma, Inc.: Strengths 24

PDL Biopharma, Inc.: Weaknesses 24

PDL Biopharma, Inc.: Opportunities 25

PDL Biopharma, Inc.: Threats 26

PDL Biopharma, Inc.: Corporate Financial Deals Activity 27

PDL Biopharma, Inc.: Financial Deals Overview 27

PDL Biopharma, Inc.: Top Deals 2014-2018YTD 29

PDL Biopharma, Inc.: Mergers and Acquisitions 30

PDL Biopharma, Inc.: Recent Developments 31

PDL Biopharma, Inc.: News and Events Summary 31

PDL Biopharma, Inc.: Business Expansion 33

PDL Biopharma, Inc.: Corporate Governance 34

PDL Biopharma, Inc.: Financial Deals 34

PDL Biopharma, Inc.: Financial Performance 35

PDL Biopharma, Inc.: Red Flags/DistressSignals 36

PDL Biopharma, Inc.: Regulatory and Legal Events 36

PDL Biopharma, Inc.: Strategy and Operations 37

Appendix 38

Contact Us 38

Methodology 38

About MarketLine 39


List Of Figure

List of Figures

Figure 1: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (TTM )

Figure 2: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: PDL Biopharma, Inc.: M&A Average Deal Size-Value (USD m)

Figure 4: PDL Biopharma, Inc.: M&A Volume and Value Trend (2014-YTD 2018)


List Of Table

List of Tables

Table 1: PDL Biopharma, Inc.: Key Facts

Table 2: PDL Biopharma, Inc.: Key Employees

Table 3: PDL Biopharma, Inc.: Locations and Subsidiaries

Table 4: PDL Biopharma, Inc.: Key Competitors

Table 5: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (TTM )

Table 6: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Table 7: PDL Biopharma, Inc.: M&A Average Deal Size-Value (USD m)

Table 8: PDL Biopharma, Inc.: Top Deals 2014-2018YTD

Table 9: PDL Biopharma, Inc.: M&A Volume and Value Trend (2014-YTD 2018)

Table 10: PDL Biopharma, Inc.: News and Events Summary

Table 11: PDL Biopharma, Inc.: Business Expansion

Table 12: PDL Biopharma, Inc.: Corporate Governance

Table 13: PDL Biopharma, Inc.: Financial Deals

Table 14: PDL Biopharma, Inc.: Financial Performance

Table 15: PDL Biopharma, Inc.: Red Flags/DistressSignals

Table 16: PDL Biopharma, Inc.: Regulatory and Legal Events

Table 17: PDL Biopharma, Inc.: Strategy and Operations

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

PDL Biopharma, Inc.-Strategy, SWOT and Corporate Finance Report

Summary

PDL Biopharma, Inc.-Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360? view of the company.

Key Highlights

PDL Biopharma, Inc., (PDL or 'the company'), formerly known as Protein Design Labs, Inc., is engaged in the research and development of humanized antibodies for cancer, immunologic diseases and other medical conditions. The company operates in the US, where it is headquartered in Incline Village, Nevada.

Scope

- Detailed information on PDL Biopharma, Inc. required for business and competitor intelligence needs

- A study of the major internal and external factors affecting PDL Biopharma, Inc. in the form of a SWOT analysis

- An in-depth view of the business model of PDL Biopharma, Inc. including a breakdown and examination of key business segments

- Intelligence on PDL Biopharma, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors

- News about PDL Biopharma, Inc., such as business expansion, restructuring, and contract wins

- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PDL Biopharma, Inc. and the factors that influence its strategies.

- Track strategic initiatives of the company and latest corporate news and actions.

- Assess PDL Biopharma, Inc. as a prospective partner, vendor or supplier.

- Support sales activities by understanding your customers' businesses better.

- Stay up to date on PDL Biopharma, Inc.'s business structure, strategy and prospects.

READ MORE

Scope

Table of Contents

Company Snapshot 2

Table of Contents 5

PDL Biopharma, Inc.: Company Overview 9

PDL Biopharma, Inc.: Overview and Key Facts 9

PDL Biopharma, Inc.: Overview 9

PDL Biopharma, Inc.: Key Facts 9

PDL Biopharma, Inc.: Key Employees 11

PDL Biopharma, Inc.: Key Employee Biographies 12

PDL Biopharma, Inc.: Major Products and Services 16

PDL Biopharma, Inc.: Company History 17

PDL Biopharma, Inc.: Management Statement 20

PDL Biopharma, Inc.: Locations and Subsidiaries 21

PDL Biopharma, Inc.: Key Competitors 22

PDL Biopharma, Inc.: Company Analysis 23

PDL Biopharma, Inc.: Business Description 23

PDL Biopharma, Inc.: SWOT Analysis 24

PDL Biopharma, Inc.: SWOT Overview 24

PDL Biopharma, Inc.: Strengths 24

PDL Biopharma, Inc.: Weaknesses 24

PDL Biopharma, Inc.: Opportunities 25

PDL Biopharma, Inc.: Threats 26

PDL Biopharma, Inc.: Corporate Financial Deals Activity 27

PDL Biopharma, Inc.: Financial Deals Overview 27

PDL Biopharma, Inc.: Top Deals 2014-2018YTD 29

PDL Biopharma, Inc.: Mergers and Acquisitions 30

PDL Biopharma, Inc.: Recent Developments 31

PDL Biopharma, Inc.: News and Events Summary 31

PDL Biopharma, Inc.: Business Expansion 33

PDL Biopharma, Inc.: Corporate Governance 34

PDL Biopharma, Inc.: Financial Deals 34

PDL Biopharma, Inc.: Financial Performance 35

PDL Biopharma, Inc.: Red Flags/DistressSignals 36

PDL Biopharma, Inc.: Regulatory and Legal Events 36

PDL Biopharma, Inc.: Strategy and Operations 37

Appendix 38

Contact Us 38

Methodology 38

About MarketLine 39


List Of Figure

List of Figures

Figure 1: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (TTM )

Figure 2: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Figure 3: PDL Biopharma, Inc.: M&A Average Deal Size-Value (USD m)

Figure 4: PDL Biopharma, Inc.: M&A Volume and Value Trend (2014-YTD 2018)


List Of Table

List of Tables

Table 1: PDL Biopharma, Inc.: Key Facts

Table 2: PDL Biopharma, Inc.: Key Employees

Table 3: PDL Biopharma, Inc.: Locations and Subsidiaries

Table 4: PDL Biopharma, Inc.: Key Competitors

Table 5: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (TTM )

Table 6: PDL Biopharma, Inc.: Deal Activity by Deal Type-Volume (2014-YTD 2018)

Table 7: PDL Biopharma, Inc.: M&A Average Deal Size-Value (USD m)

Table 8: PDL Biopharma, Inc.: Top Deals 2014-2018YTD

Table 9: PDL Biopharma, Inc.: M&A Volume and Value Trend (2014-YTD 2018)

Table 10: PDL Biopharma, Inc.: News and Events Summary

Table 11: PDL Biopharma, Inc.: Business Expansion

Table 12: PDL Biopharma, Inc.: Corporate Governance

Table 13: PDL Biopharma, Inc.: Financial Deals

Table 14: PDL Biopharma, Inc.: Financial Performance

Table 15: PDL Biopharma, Inc.: Red Flags/DistressSignals

Table 16: PDL Biopharma, Inc.: Regulatory and Legal Events

Table 17: PDL Biopharma, Inc.: Strategy and Operations

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS